Drug & supplement interaction

L-ornithine-l-aspartate + Temozolomide

Temozolomide brand name: Temodar.

No Known Interaction
The bottom line No known interaction

We found no known interaction between L-ornithine-l-aspartate and Temozolomide in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first. Additionally, although there is no interaction, the label for Temozolomide states a food rule worth keeping to, and the two are separately associated with some of the same side effects, which would make a new symptom harder to attribute to one or the other.

Know someone taking this? Share
Interaction report

L-ornithine-l-aspartate and Temozolomide

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Temozolomide and L-ornithine-l-aspartate in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

Worth understanding: our licensed dataset holds no drug-interaction record for L-ornithine-l-aspartate at all — not against Temozolomide, and not against any other medication we track. This verdict therefore rests on the absence of any recorded data, not on research that looked at this combination and found nothing. We cannot rule an interaction out.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

L-ornithine-l-aspartate safety at a glance

L-ornithine-l-aspa... overall Use caution Generally used under medical supervision for liver disease; self-treating serious liver problems is not advised.
Pregnancy Avoid Safety has not been established in pregnancy, so it is best avoided unless a doctor directs otherwise.
Breastfeeding Avoid There is not enough safety information during breastfeeding, so avoid unless advised by your doctor.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Temozolomide and L-ornithine-l-aspartate? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
What to actually watch for

No Interaction Found — But Data Suggests L-ornithine-l-aspartate and Temozolomide May Share Several of the Same Side Effects

This is not an interaction. Neither one changes how your body handles the other, and nothing here says they react together. What our sources do show is that each has separately been linked to the effects below — so taking both can make those effects more likely to turn up, and harder to pin on one or the other if they do.

  • Vomiting / Nausea Additional detail

    L-ornithine-l-aspartate

    “Intravenously, L-ornithine-L-aspartate has caused nausea and vomiting, and, less frequently, diarrhea. Slowing down the rate of infusion can prevent nausea and vomiting.”

    L-ornithine-l-aspartate · Natural Medicines adverse-effect record, reported in diarrhea.

    3 sources cited
    1. 67394. Ahmad, I., Khan, A. A., Alam, A., Dilshad, A., Butt, A. K., Shafqat, F., Malik, K., and Sarwar, S. L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy. J.Coll.Physicians Surg.Pak. 2008;18(11):684-687.
    2. 94907. Waghray A, Waghray N, Mullen K. Management of covert hepatic encephalopathy. J Clin Exp Hepatol 2015;5:S75-81. PubMed
    3. 94911. Pérez Hernández JL, Higuera de la Tijera F, Serralde-Zúñiga AE, Abdo Francis JM. Critical analysis of studies evaluating the efficacy of infusion of L-ornithine L-aspartate in clinical hepatic encephalopathy in patients with liver failure. Ann Hepatol 201

    Temozolomide

    Listed in the ADVERSE REACTIONS section of the FDA label for Temozolomide. Read the label on DailyMed ›

Reported for L-ornithine-l-aspartate but not commonly for Temozolomide: muscle pain, diarrhea and cough.

Effects for Temozolomide come from the ADVERSE REACTIONS section of its FDA label; effects for L-ornithine-l-aspartate come from the Natural Medicines adverse-effect record, quoted above. Wording is matched across sources by our own clinical vocabulary, so treat this as a prompt to pay attention, not a diagnosis.

How to take them

Some Temozolomide Products Have a Food Rule — L-ornithine-l-aspartate Should Not Break It

At least one FDA label for a product containing Temozolomide says to take it on an empty stomach. Most supplements — L-ornithine-l-aspartate included — are taken with a meal, so the easy mistake is swallowing both together at breakfast. Where that rule applies, keep Temozolomide on its own and move L-ornithine-l-aspartate to a meal later in the day.

This may not be true of your version. Food instructions belong to the product, not the ingredient: two Temozolomide products can carry different directions, and extended-release forms often differ from immediate-release ones. The label we read is quoted below — check the directions on your own box or bottle, or ask your pharmacist, for how to take the exact product you were given.

To reduce nausea and vomiting, take TEMODAR on an empty stomach or at bedtime and consider antiemetic therapy prior to and following TEMODAR administration.

From the Dosage and Administration section of the FDA label we read for Temozolomide — where that label names a specific product, the instruction is that product's. Read the label on DailyMed ›

A food rule is not an interaction — it is about how much of the medicine you absorb. The directions that came with your own product, and your pharmacist, outrank anything on this page.

From our Q&A

Questions About L-ornithine-l-aspartate or Temozolomide

These are real questions from readers, answered by the pharmacists at HelloPharmacist — written by a person, not generated from a database. Each one covers L-ornithine-l-aspartate or Temozolomide, not necessarily both, but if one is close to what you were about to ask it will usually go further than a database entry can:

Not quite your question? Ask our pharmacists directly — it is free, there is no account required, and answers usually come back within 24 hours.

Everything else you take

See Every Supplement That Interacts With Temozolomide

This page covers L-ornithine-l-aspartate only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Temozolomide page lists 25 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Activated Charcoal (major), Acerola (moderate), Alpha-lipoic Acid (moderate), Coenzyme Q10 (moderate) and Coffee Charcoal (moderate).

By severity: 1 major · 14 moderate · 10 minor.

From our pharmacist’s overview on the Temozolomide page

“Temozolomide (Temodar) is an oral chemotherapy pill, usually prescribed for aggressive brain tumors, and stakes that high make me treat this list with real caution. Most of the 25 supplements on file interfere in the gut, where fibers, gums, and charcoals may bind the drug or change how much of it gets absorbed.”

Reviewed by 2 · Jul 18, 2026

Open the Temozolomide interaction page

One more smart check

Taking L-ornithine-l-aspartate as Part of a Dietary Supplement Product? Check It for Interactions

We hold 92 real supplement products containing L-ornithine-l-aspartate, each one broken down to its full ingredient list — and combination products often carry several ingredients besides L-ornithine-l-aspartate. Even though L-ornithine-l-aspartate itself has no known interaction with Temozolomide, another ingredient on your label might. Find your product and we’ll check every ingredient on its label:

How much people look this up

Where L-ornithine-l-aspartate and Temozolomide Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement L-ornithine-l-aspartate
Steady interest

#1,299 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Temozolomide
Steady interest

#2,351 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every L-ornithine-l-aspartate reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 13, 2026. The L-ornithine-l-aspartate and Temozolomide records this page draws on were last updated July 10, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About L-ornithine-l-aspartate

What is L-ornithine-l-aspartate?

L-ornithine-l-aspartate
  • Liver-related brain symptoms (hepatic encephalopathy)
  • Lowering blood ammonia levels
  • Support in cirrhosis and fatty liver
  • General liver support

L-ornithine-L-aspartate (LOLA) is a combination of two amino acids studied mainly for lowering ammonia in people with liver disease and helping manage hepatic encephalopathy. There is reasonable clinical evidence for this specific medical use, but it should be used under medical supervision rather than as a casual 'liver detox' supplement. Talk to your doctor or pharmacist before using it, especially if you have liver or kidney problems.

Oral granules/powder, tablets, oral solution, and intravenous infusion (in clinical settings)

An interaction check asks whether these two react with each other — it does not ask whether L-ornithine-l-aspartate is a good idea for someone in your situation. Here is what our L-ornithine-l-aspartate record says about it on its own.

L-ornithine-l-aspartate: dosing

There is no single standardized over-the-counter dose for L-ornithine-L-aspartate, and the amounts used in studies were often given in a hospital or clinical setting. Oral and IV forms are dosed differently, and the right amount depends on the condition being treated.If you are using a supplement product, follow the directions on the label and do not exceed them.

From our L-ornithine-l-aspartate monograph — the full record covers uses, side effects and every documented interaction.

Read the full L-ornithine-l-aspartate monograph & all interactions
Medication

About Temozolomide

What Is Temozolomide Used For?

Brand name: Temodar

Temozolomide treats two types of aggressive brain tumors in adults: glioblastoma and anaplastic astrocytoma. For newly diagnosed glioblastoma, it is given alongside radiation therapy and then continued as maintenance treatment.

For anaplastic astrocytoma, Temodar (the brand-name injection/capsule product) is approved for adjuvant treatment of newly diagnosed cases as well as refractory cases (tumors that have stopped responding to other treatment). Temozolomide Capsules, USP are approved for newly diagnosed glioblastoma and for refractory anaplastic astrocytoma in patients whose disease progressed on a regimen containing nitrosourea and procarbazine.

Most-Reported Side Effects for Temozolomide

From FAERS, the FDA’s public side-effect reporting system (20,946 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Disease progression 1,887 reports
Thrombocytopenia 1,569 reports
Nausea 1,310 reports
Fatigue 1,037 reports
Neutropenia 1,035 reports
See full Temozolomide drug information
Keep checking

Other Drugs & L-ornithine-l-aspartate

Browse every other medication we’ve checked against L-ornithine-l-aspartate — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
0Moderate
0Minor
2,829No known interaction
No interaction 2,829 drugs checked — show the list
Evidence & sources

L-ornithine-l-aspartate References

The 3 references that drive our L-ornithine-l-aspartate monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Ahmad, I., Khan, A. A., Alam, A., Dilshad, A., Butt, A. K., Shafqat, F., Malik, K., and Sarwar, S. L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy. J.Coll.Physicians Surg.Pak. 2008;18(11):684-687.
  2. Waghray A, Waghray N, Mullen K. Management of covert hepatic encephalopathy. J Clin Exp Hepatol 2015;5:S75-81. PubMed
  3. Pérez Hernández JL, Higuera de la Tijera F, Serralde-Zúñiga AE, Abdo Francis JM. Critical analysis of studies evaluating the efficacy of infusion of L-ornithine L-aspartate in clinical hepatic encephalopathy in patients with liver failure. Ann Hepatol 201

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking L-ornithine-l-aspartate and Temozolomide Together: Common Questions

Is it safe to take L-ornithine-l-aspartate with Temozolomide?
We do not list a known interaction between L-ornithine-l-aspartate and Temozolomide. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Do L-ornithine-l-aspartate and Temozolomide have any of the same side effects?
Yes — our sources link each of them separately to 2 of the same effects. That is not an interaction: neither changes how your body handles the other. It does mean that if one of those effects turns up, it can be harder to tell which one is behind it. They are listed on this page with the source behind each.
Should I take L-ornithine-l-aspartate and Temozolomide at the same time of day?
At least one FDA label for a product containing Temozolomide says to take it on an empty stomach, and supplements are usually taken with a meal — so taking them together at breakfast is the easy mistake. Where that applies, keep Temozolomide on its own and move L-ornithine-l-aspartate to a meal later in the day. Food instructions belong to the product rather than the ingredient, so check the directions on your own box. This is about absorption, not an interaction.
Does Temozolomide interact with any supplements?
Yes. Temozolomide has documented interactions with 25 supplements in our database — L-ornithine-l-aspartate is not one of them. The Temozolomide interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Temozolomide and L-ornithine-l-aspartate?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.